| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | BRD4132 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.04 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.04 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.04 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.071 | 0.04 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.05 |